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Abstract
Pulmonary arterial hypertension (PAH) is a syndrome characterized by progressive lung vascular remodelling, endothelial cell (EC)
dysfunction, and excessive inflammation. The primary cilium is a sensory antenna that integrates signalling and fine tunes EC
responses to various stimuli. Yet, cilia function in the context of deregulated immunity in PAH remains obscure. We hypothesized
that cilia function is impaired in ECs from patients with PAH due to their inflammatory status and tested whether cilia length
changes in response to cytokines. Primary human pulmonary and mouse embryonic EC were exposed to pro- (TNFa, IL1b, and
IFNg) and/or anti-inflammatory (IL-10) cytokines and cilia length was quantified. Chronic treatment with all tested inflammatory
cytokines led to a significant elongation of cilia in both control human and mouse EC (by 1 mm, P< 0.001). This structural
response was PKA/PKC dependent. Intriguingly, withdrawal of the inflammatory stimulus did not reduce cilia length. IL-10, on the
other hand, blocked and reversed the pro-inflammatory cytokine-induced cilia elongation in healthy ECs, but did not influence basal
length. Conversely, primary cilia of ECs from PAH patients were significantly longer under basal conditions compared to controls
(1.86 0.02 vs. 2.43 0.08 mm, P¼ 0.002). These cilia did not elongate further upon pro-inflammatory stimulation and anti-
inflammatory treatment did not impact cilia length. The missing length modulation was specific to cytokine stimulation, as appli-
cation of fluid shear stress led to increased cilia length in the PAH endothelium. We identified loss of cilia length regulation upon
cytokine stimulation as part of the endothelial dysfunction in PAH.
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Introduction
Pulmonary arterial hypertension (PAH) represents a group
of lung diseases characterized by high pulmonary artery
pressure (PAP) (> 25mmHg) eventually leading to right
heart failure.1,2 Blood vessels in the lungs of PAH patients
are highly remodeled due to genetic changes, altered cellular
signaling, metabolic changes, aberrant pressures, and
chronic inﬂammation.2–4
PAH patients have a high inﬂammatory status both in
the systemic circulation and in the lung vasculature.4
Vascular inﬂammation involves various cytokines, including
the pro-inﬂammatory TNFa, IL1b, and IFNg, as well as the
anti-inﬂammatory cytokine IL10. Under the inﬂuence of
pro-inﬂammatory cytokines, endothelial cells (ECs) express
proteins, such as cell adhesion molecules, for the recruitment
of blood borne inﬂammatory cells into the vessel wall.5,6
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Chronic or dysregulated inﬂammation leads to EC dysfunc-
tion involving a number of factors, such as loss of barrier
integrity.5,7
As with most mammalian cell types, ECs carry primary
cilia. The main structural part of the cilium is the rigid axo-
neme consisting of 9þ 0 microtubule doublets, which pro-
trudes from the cellular membrane into the lumen or
extracellular space.8 The base of the cilium, the transition
zone, functions as an active barrier for both the cytoplasmic
and membrane content preventing free exchange and contri-
buting to a unique subcellular environment.9 The endothelial
primary cilium is a highly regulated and speciﬁed antenna
that senses and orchestrates responses to chemical and mech-
anical cues from the ﬂowing blood.10,11 Emerging data fur-
ther identify the primary cilium as a specialized organelle
involved in intracellular signaling processes from hedgehog
proteins, growth factors, calcium, and others.12–19
Furthermore, EC primary cilia are important for vascular
integrity and homeostasis, since absence of primary cilia
has been shown to promote endothelial-to-mesenchymal
transition (EndoMT).20 In accordance, primary cilia were
found in areas of disturbed ﬂow and are therefore suggested
to protect against shear-induced EndoMT.21,22
Cilia length is instrumental for cilia function and is con-
trolled by intraﬂaggelar transport (IFT). Cilia length itself
can regulate cargo loading of the IFT particles (e.g. with
receptors), suggesting that signaling directly links to cilia
length.23 In addition, many signaling pathways have been
shown to inﬂuence cilia length.24–26 As such, cilia length
increases in response to pro-inﬂammatory cytokines and
was thereby proposed to mediate inﬂammatory responses.27
In diseases with dysregulated vascular inﬂammation,
such as PAH, ECs are chronically exposed to vast amounts
of pro-inﬂammatory cytokines. Hence, we hypothesized that
the loss of cytokine-induced cilia length control is part of the
EC dysfunction in PAH and tested whether cytokines can
aﬀect cilia length of human pulmonary microvascular EC
from patients.
Methods
Cell culture
Cells were grown on 0.1% gelatin coated eight-chamber
slides (BD Biosciences) until conﬂuency. Ciliated mouse
embryonic endothelial cells (MEC)28 were cultured as pre-
viously described.20 Primary human pulmonary microvascu-
lar endothelial cells (MVEC) were obtained from end-stage
PAH patients and healthy tissues of lobectomy donors, as
described before.29 The tissue harvest and MVEC isolations
were approved by the IRB of the VU University Medical
Center (VUmc, Amsterdam, The Netherlands) and consent
was given. MVEC were cultured in complete ECM medium
supplemented with 1% pen/strep, 1% endothelial cell
growth supplement, and 5% FCS (ScienceCell). Shear
stress was applied, as previously described,29 by culturing
cells on m-slides I Luer (ibidi) and applying medium ﬂow
at 15 dyn/cm2 over the adherent cells with the ibidi pump
system for ﬁve days.
Treatments
Treatments were performed in starvation medium with 1%
FCS and pen/strep. Stimuli were provided in fresh medium
for 24 h. The following concentrations were used: TNFa
10 ng/mL, IL1b 10 ng/mL, IFNg 100U/mL, and IL10
10 ng/mL. Forskolin (FK) was used in a concentration of
100mM (Sigma-Aldrich). H89 and Go¨6983 (Sigma-Aldrich)
were applied at 10 mM and 2 mM, respectively. The NFkB
inhibitor BAY 11-7085 (Cayman Chemicals) was applied at
1 mM ﬁnal concentration.
Cilia immunostaining
Cells were ﬁxed in 4% paraformaldehyde (Merck) in PBS
for 10min at room temperature (RT). Fixed cells were per-
meabilized with 0.05% Tween 20 (Merck) in PBS.
Incubation with the primary antibody against acetylated-
a-tubulin (6-11B-1, 1:2000, Sigma-Aldrich) was performed
overnight at 4C. This was followed by 1 h incubation with
secondary Cy3-labeled goat-anti-mouse antibody (1:500,
Vector Laboratories) and DAPI nuclear counterstaining
(1:1000, Molecular Probes) for 5min at RT. Samples were
mounted in Prolong Gold (Molecular Probes).
Cilia length measurements
Confocal z-stacks were taken with a ﬁxed step distance of
0.25lm using a SP5 confocal microscope (Leica). Image
acquisition and cilia length measurements were performed
as described previously.30 In short, a random population of
at least ten cilia per condition were measured using the
Pythagoras (PyT) method. Herefore, cilium length was
determined in the xy- as well as in z-direction with ImageJ
(NIH) and the three-dimensional length was calculated
based on the Pythagorean theorem a2þb2¼ c2, with a
being the xy-length based on a maximum intesity projection
(MIP) and b the z-length (Fig. 1, schematic). With the PyT
method, the spatial orientation of the cilium is accounted
for, wherefore selection bias and standard deviation are
minimized.
Statistics
Experiments in MEC were performed in duplicate and
repeated three times, experiments with MVEC were per-
formed in duplicate in at least three donors. Statistics were
calculated based on the averaged cilia length per donor with
the total number of donors used as independent n. Data
visualization and statistics were generated with GraphPad
Prism 7. Data are presented as mean SEM. Samples were
tested for Gaussian distribution by D’Agostino-Pearson
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omnibus normality test. If not otherwise indicated,
signiﬁcance was determined by one-way ANOVA with
Kruskal–Wallis test and Dunn’s post hoc test. *P¼ 0.033,
**P¼ 0.002, ***P< 0.001
Results
TNFa induces sustained cilia elongation
We sought to determine whether TNFa inﬂuences cilia
length dose dependently. Therefore, diﬀerent concentrations
of TNFa were tested on MEC (Fig. 1a). A low concentra-
tion of 2.5 ng/mL TNFa induced signiﬁcant cilia elongation
compared to unstimulated controls (1.96 0.04 to
2.37 0.05 mm, P¼ 0.002). Cilia length plateaued at an aver-
age length of approximately 3 mm with a concentration of
10 ng/mL or higher (P< 0.001). An additional increase in
TNFa concentration did not further increase cilia length.
To examine the time course of cilia elongation upon
TNFa stimulation, cilia length was measured at various
time points (Fig. 1b). Indeed, cilia elongation upon TNFa
stimulation was time-dependent. At 2 h after treatment, cilia
elongation was visible, although not signiﬁcant. Length was
signiﬁcantly increased 4 h after treatment (P< 0.001) and
reaches a plateau after 8 h. The stimulation with TNFa
caused sustained elongation and no signiﬁcant diﬀerences
in cilia length were found between 8 h and 48 h after
treatment.
Additionally, we tested whether the removal of TNFa
would reverse cilia length (Fig. 1c). To our surprise, wash-
ing steps after 16 h, 24 h, or 48 h did not alter cilia length.
Moreover, additive treatment after 16 h, 24 h, or 48 h with
TNFa did not show an extra eﬀect on cilia length. Taken
together, 8 h of TNFa treatment with a concentration of
10 ng/mL is suﬃcient to reach TNFa-induced maximal
average cilia length and retain cilia elongation for at least
48 h.
Various pro-inflammatory cytokines stimulate
cilia elongation
To investigate whether various pro-inﬂammatory cytokines
stimulate cilia elongation, MEC were exposed to either
TNFa, IL1b, or IFNg (Fig. 1d). In general, cilia length sig-
niﬁcantly increased from approximately 2 mm to approxi-
mately 3 mm after stimulation (P< 0.001). FK was used as
Fig. 1. Various pro-inflammatory cytokines elongate primary cilia permanently. (a) TNFa was applied to MEC in different concentrations for 24 h
(n 100 per concentration). (b) Time course of cilia elongation was quantified in MEC after addition of 10 ng/mL TNFa (n 43 cilia per time
point). (c) Cilia length was determined after an initial trigger of 8h TNFa (10 ng/mL) followed by additional stimulation or an alternative wash step
after 16 h, 24 h, or 48h. All conditions were fixed and quantified after 56 h (n 34 cilia per condition). (d) Maximum intensity projections (MIP) of
representative (flat) cilia (arrow heads) upon 24 h treatment with TNFa (10 ng/mL), IL1b (10 ng/mL), IFNg (100U/mL), or the positive control FK
(100 lM) (scale bar¼ 5lm). Schematic depicts differences between MIP used to determine xy-length and three-dimensional (3D) length cal-
culation applied for cilia length analysis and statistics. Quantification of average 3D cilia length is shown to the right (n 53 per condition).
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a positive control and did show the same average cilia elong-
ation as the inﬂammatory cytokines.
Since cells responding to stimulation have considerable
cilia length variations, their frequency distribution was ana-
lyzed (Suppl. Fig. 1). The cytokine and FK stimulated sam-
ples showed a shift in frequency distribution towards longer
cilia compared to controls. Cilia of 2 mm were still present,
indicative for cells that did not respond to stimulation, but
the majority elongated to approximately 3 mm and some
individual cilia even up of 7 mm.
Cytokine-induced cilia elongation is dependent on PKC-
dependent/PKC signaling
It has been shown that primary cilia elongate upon direct
stimulation of cyclic AMP with concomitant activation of
PKC-dependent.31 Involvement of PKC-dependent/PKC
signaling in ciliary extension upon TNFa was tested by
chemical inhibition with H89 or Go¨6983 (Fig. 2). H89
and Go¨6983 alone did not alter cilia length in MEC com-
pared to basal condition. In agreement with the previous
experiments, cilia length signiﬁcantly increased to an
average of approximately 3 mm upon TNFa stimulation
(P< 0.001). Importantly, inhibition of PKA and PKC
prevented TNFa-induced elongation. Similar results
were obtained with IL1b, IFNg, or the direct PKA acti-
vator FK (Suppl. Fig. 2A). In the presence of the inhibi-
tors, none of the tested stimuli altered cilia length
suggesting that cilia elongation by inﬂammatory cyto-
kines is transduced through PKA/PKC dependent
signaling.
To conﬁrm the importance of PKC signaling more spe-
ciﬁcally, PKC knockdown was performed by shRNA. The
knockdown was suﬃcient to prevent TNFa-induced elong-
ation (Suppl. Fig. 2B). The use of the lentiviral construct
resulted in viable cells with a 60% decrease in PKC mRNA
levels (Suppl. Fig. 2C).
IL10 blocks and reverses cilia elongation upon
cytokine stimulation
We reasoned that when cells react to inﬂammatory cyto-
kines by elongating their primary cilia, anti-inﬂammatory
stimuli might counteract this response. Therefore, we
tested whether IL10 prevents and reverses pro-inﬂammatory
cytokine-induced cilia elongation.
MEC were treated with basal medium, TNFa, or IL10
alone for 12h. Afterwards either IL10 or TNFa were added
on top of the previous stimulus for additional 12h (Fig. 3a).
In agreement with our previous experiments, 12h or 24h of
TNFa stimulation alone showed signiﬁcant cilia elongation
to 3mm (P< 0.001). IL10 alone did not inﬂuence cilia
length compared to basal condition. Importantly, application
of IL10 to TNFa blocked cilia elongation and IL10 added
after TNFa reversed cilia length back to basal levels. The
eﬀect of IL10 on cilia length was not exclusive to TNFa,
but identical upon IL1b, IFNg, and IL10 blocked the eﬀect
of direct PKA activation by FK stimulation (Suppl. Fig. 3A).
Interestingly, its inhibitory function was dependent on the
actual presence of IL10. Pre-treatment with IL10 followed
by FK without IL10 in the medium was not suﬃcient to
prevent elongation (Suppl. Fig. 3B). In conclusion, IL10
blocked and reversed cilia elongation upon stimulation with
various inﬂammatory cytokines.
Cilia cytokine responses are similar in mouse and
human endothelial cells
Primary cilia are highly conserved among species, wherefore
their mechanisms might be as well. To examine, whether the
Fig. 2. Cilia elongation upon inflammatory cytokines is PKA/PKC-dependent. MEC were stimulated for 24 h with different combinations of
TNFa (10 ng/mL) and/or the PKA inhibitor H89 (10mM) or PKC inhibitor Go¨6983 (2 mM) (n 43 cilia per condition). The PKA activator FK was
used as positive control.
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primary cilia of human lung EC react in a similar manner to
the pro-inﬂammatory TNFa and anti-inﬂammatory IL10 as
mouse EC, we repeated the combination treatments in
MVEC from healthy control lungs (Fig. 3b and c). Indeed,
12 h and 24 h of TNFa showed a signiﬁcant cilia elongation
to approximately 3 mm (P< 0.001) compared to basal length
of 2 mm. Again, IL10 alone had no eﬀect on basal cilia
length. When combined with TNFa, IL10 blocked cilia
elongation, while IL10 applied 12 h after TNFa reversed
cilia length back to basal levels.
Endothelial cells of PAH patients display elongated cilia
To test, whether cilia length diﬀers between patient and
control MVEC, cilia were quantiﬁed in samples of three
control and three donors with PAH (Fig. 4a). Under
basal conditions the average length of cilia on EC
from PAH patients was signiﬁcantly increased to
2.43 0.08mm compared to 1.86 0.02 mm of the controls
(P¼ 0.002).
TNFa and IL10 do not affect cilia length in PAH cells
Healthy MEC and MVEC showed cilia elongation upon
stimulation with inﬂammatory cytokines to 3 mm. IL10
could shorten cilia and block the eﬀects of TNFa.
PAH patient-derived MVEC exerted elongated cilia under
basal conditions already (Fig. 4a), wherefore we tested
cilia length responses in these patient cells (Fig. 4b). To
our surprise, treatment with TNFa had no additional eﬀect
on cilia length and IL10 treatment of PAH MVEC did
neither reduce basal cilia length nor aﬀected the response
to TNFa. To answer whether speciﬁcally the response
to IL10 was lost or if cilia of PAH cells are generally
unresponsive to anti-inﬂammatory treatment, the NFkB
inhibitor BAY 11-7085 was tested. BAY 11-7085
Fig. 3. IL10 blocks and reverses cilia elongation upon inflammatory cytokine stimulation in mouse and human endothelial cells. (a) MEC were
either incubated with IL10 (10 ng/mL), TNFa (10 ng/mL), or left untreated for 12 h. Subsequently, different combinations of TNF or IL10 were
added directly into the previous conditions and incubated for another 12 h (n 26 cilia per condition). (b) The combination treatments were
repeated in human pulmonary MVEC of healthy individuals (donor¼ 3, n 28 cilia per condition). (c) MIP of representative cilia (arrowheads) on
MVEC under the different conditions.
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showed similar responses like IL10 blocking the eﬀects of
TNFa in controls but leaving elongated basal PAH cilia
unchanged.
The sheared PAH endothelium showes increased
cilia length
To further elucidae, if PAHMVEChave completely lost their
cilia length regulation ability, ﬂuid shear stress was tested as
trigger (Fig. 4c). Primary cilia of PAH MVEC were found
signiﬁcantly elongated to 4.87 0.46 mm compared to
2.09 0.17 mm of controls (P< 0.001) after ﬁve days of
high shear stress. Additionally, while cilia of the sheared con-
trols were localized towards the leading edge of the cells in the
direction of ﬂow and migration, cilia of PAH MVEC were
found randomly positioned around the nucleus.
Discussion
Microvascular EC from lungs of patients with PAH display
elongated cilia. These cells are incapable to adapt their cilia
length in response to pro- and anti-inﬂammatory cytokine
stimulation.
Primary cilia play a pivotal role in vascular integrity and
homeostasis. Cilia dysfunction is implicated in several
pathologies, such as atherosclerosis and developmental dis-
eases. Among the variety of ciliopathies, cilia can be elon-
gated, truncated, less present, or completely absent.26 In the
Joubert syndrome, patients show less and shortened cilia.32
In contrast, the phenotype of Meckel-Gruber syndrome is
elongated cilia. Most patients with Bardet-Biedl syndrome
show truncated cilia,26 although patients with one speciﬁc
subtype have elongated renal epithelial cilia.33 In addition to
Fig. 4. PAH patient-derived endothelial cells exert elongated cilia that are non-responsive to pro- and anti-inflammatory treatment but respond
to fluid shear stress. (a) MVEC from controls and PAH lungs were grown to confluency and did not receive additional treatment. Cilia length was
quantified. Samples were normally distributed and significance was calculated using an unpaired student’s t-test on their average lengths
(donor¼ 3, n 10 per donor). (b) Healthy controls (gray) and PAH-derived MVEC (black) were stimulated with TNFa, IL10 (both 10 ng/mL),
NFkB inhibitor (1mM) alone, or a combination of TNFa and a inhibitor. Cilia length was normalized to intra-experimental controls (basal)
(donor 3, n 10 per donor and condition). (c) Control and PAH MVEC were subjected to high fluid shear stress (15 dyn/cm2) for five days and
cilia length was quantified. Representative phase-contrast and fluorescence staining are shown. Arrows indicate direction of flow. Cilia length was
quantified and differences were calculated with an unpaired student’s t-test.
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variations in cilia form across diﬀerent ciliopathies, there is
considerable heterogeneity in cilia function dependent on
host cell and vascular bed. Renal cilia play a part in repair
processes; they elongate upon renal injury and decrease in
length during renal repair.34 In chondrocytes, cilia shorten
upon mechanical loading to minimize cell sensitivity to pro-
longed activation.35 In mesenchymal stem cells, cilia elong-
ation has been shown important for diﬀerentiation.36 Taken
together, cells change their cilia length in response to envir-
onmental cues. When this process is dysfunctional, initial
adaptation is disturbed and homeostasis and repair
impaired.
PAH is a fatal group of diseases with a high inﬂamma-
tory status.4 Cilia length increases in response to pro-
inﬂammatory cytokines and was thereby proposed to
mediate inﬂammatory responses.27 Hence, we tested the
pro-inﬂammatory cytokines TNFa, IL1b, and IFNg on
healthy EC and all three cytokines provoked a similar
increase in average cilia length to 3 mm. Thereby, not
only the increase in length but also the length distribution
was comparable between the various cytokines. This indi-
cates a generic mechanism for cilia elongation upon inﬂam-
matory stimuli, since the cytokines themselves act through
unique receptors and signaling pathways.5 Moreover, simi-
lar eﬀects were observed between mouse and human ECs,
which point towards a conserved mechanism among species.
Chondrocytes have been shown to elongate cilia upon
IL1b stimulation in a PKA/PKC-dependent manner.27 In
line with this ﬁnding, we show that PKA and PKC inhib-
ition prevented cilia elongation after stimulation with the
inﬂammatory cytokines. Interestingly, PKA/PKC signaling
was not necessary to express cilia and basal length was not
aﬀected by PKA or PKC inhibition. Therefore, PKA/PKC
signaling is predominantly needed for cilia elongation and
might present a common integrator for various stimuli.
To consider, the individual stimuli might cause subtile
diﬀerences in absolute cilia length. Using the PyT methode
to determine average cilia length keeps selection bias min-
imal. However, subtile length diﬀerences <0.2 mm might be
underestimated.30 What controls maximal cilia length and
what absolute minimal change of length is functionally
important remains to be resolved.
To reverse cilia length, removing the inﬂammatory stimu-
lus was not suﬃcient, but application of the anti-inﬂamma-
tory cytokine IL10 was needed to shorten the extended cilia
back to basal levels demonstrating the need for active cues
to switch EC from a pro- to anti-inﬂammatory state. In
addition, IL10 (or NFkB inhibition) could block cilia elong-
ation upon inﬂammatory cytokines and FK. Here, the eﬀect
was direct and reversible and left basal cilia length unaﬀected.
Interestingly, the eﬀect of IL10 was general for all tested
cytokines and conserved in mouse and human EC. The pre-
cise mechanism of IL10 regulating cilia length remains to be
determined. A direct eﬀect of IL10 on PKA/PKC was not yet
shown, while PKA itself is involved in IL10 production.37
Recent literature showed that the eﬀects of TNFa, INFg,
and IL10 might, at least in part, be regulated independent
of PKA via the SOCS (suppressor of cytokine signaling)
pathway.37 The authors found a synergistic activation of
SOCS-3 when combining IL10 and cyclic AMP treatment
that was independent from PKA activation.
When repeating the stimulations in MVEC from patients
with PAH, we found that cilia were already elongated under
basal conditions compared to controls. Therefore, we
assumed that treatment with IL10 would reduce cilia
length. To our surprise, PAH ECs did neither respond to
pro- nor anti-inﬂammatory cytokines with a variation of
cilia length. The basal elongation and loss of TNFa
response might be an adaptation to the excessive amounts
of pro-inﬂammatory cytokines produced by the diseased
cells and the chronic state of inﬂammation in patient
lungs.4 However, the failure of IL10 to reduce cilia length
might alternatively indicate that the basal elongation is inde-
pendent from inﬂammatory signaling but rather due to
metabolic changes.38 Of interest, longer cilia are known to
be associated with decreased proliferation39 and thereby
might be the cells attempt to counteract the hyper-prolifera-
tive phenotype characteristic to the PAH endothelium.40 In
accordance with this line of reasoning, PAH patients with
high levels of IL10 have a worse prognosis.41 On the con-
trary, higher IL10 levels are also suggested as compensatory
mechanism in more advanced stages of the disease. In add-
ition, administration of IL10 prevented development of PH
in the monocrotaline rat model a model characterized by
severe inﬂammation.42
Application of ﬂuid shear stress (instead of cytokines)
signiﬁcantly altered cilia length of PAH cells, wherefore
the loss of cilia length control seems speciﬁc to cytokine
stimulation. Nevertheless, cilia of sheared PAH cells were
longer than of controls and randomly localized around the
nucleus, although they should be oriented towards the lead-
ing edge of the shear adapted cells, such as seen in the con-
trols. This indicates defective mechano-responses and cell
polarity in the sheared PAH cells, which might be a conse-
quence of the defective shear sensing and delayed morpho-
logical adapation that we reported earlier.29 However,
mono-motile cilia are linked to cell polarity, directed migra-
tion, and wound repair43 pointing towards a generally
dysfunctional PAH endothelial responsiveness to micro-
environmental cues that might manifest through or, at
least partly, be caused by the dysfunctional cilium.
To summarize, longer cilia are an inherent feature of
PAH MVEC. The sustained elongation of primary cilia
and a loss of length regulation function upon cytokine
stimulation might represent an adaptive response to the
chronic inﬂammation and act as a rescue mechanism to pre-
vent further recruitment of blood-borne inﬂammatory cells
into the vessel wall of patient lungs and decrease EC prolif-
erative rates. However, the functional consequences of cilia
non-responsivness on intra-endothelial signaling and the
surrounding tissue remain subject to further studies. Here,
investigating defective cilia elongation in response to
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inﬂammatory cytokines might reveal downstream cellular
changes contributing to disease progression. Additionally,
restoring cilia responses to anti-inﬂammatory treatment in
ECs from PAH patients might decelerate disease progres-
sion by maintaining the EC phenotype.
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